enGene Therapeutics Stock Forecast

Stock Price Forecast

The 8 analysts with 12-month price forecasts for enGene Therapeutics stock have an average target of 8.44, with a low estimate of 2.00 and a high estimate of 28. The average target predicts an increase of 382.29% from the current stock price of 1.75.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$2.00	$8.44	$4.00	$28
Change	+14.29%	+382.29%	+128.57%	+1500.0%

Analyst Ratings

The average analyst rating for enGene Therapeutics stock from 11 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	7	7	7	7	2	2
Buy	3	3	3	3	1	1
Hold	1	1	1	1	8	7
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	1
Total	11	11	11	11	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Judah Frommer Morgan Stanley	Morgan Stanley	Sell Downgrades n/a	Sell	Downgrades	n/a	n/a	Jun 18, 2026
Michael Schmidt Guggenheim	Guggenheim	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Jun 16, 2026
Andres Y. Maldonado H.C. Wainwright	H.C. Wainwright	Buy Maintains $6 → $4	Buy	Maintains	$6 → $4	+128.57%	Jun 16, 2026
Yanan Zhu Wells Fargo	Wells Fargo	Hold Reiterates $2	Hold	Reiterates	$2	+14.29%	Jun 16, 2026
David Dai UBS	UBS	Hold Maintains $9 → $2	Hold	Maintains	$9 → $2	+14.29%	May 14, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

6.17M

EPS This Year

-1.73

from -2.29

EPS Next Year

-1.40

from -1.73

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Oct 31, 2021	Oct 31, 2022	Oct 31, 2023	Oct 31, 2024	Oct 31, 2025	Oct 31, 2026	Oct 31, 2027
Revenue	-	-	-	-	-	-	6.17M
Revenue Growth	-	-	-	-	-	-	-
EPS	-6.25	-44.30	-151.22	-1.46	-2.29	-1.75	-1.53
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	8	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	14.7M
Avg	n/a	6.2M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2027	2028
High	-	987.8%
Avg	-	485.1%
Low	-	45.9%

EPS Forecast

EPS	2026	2027
High	-1.56	-0.91
Avg	-1.73	-1.40
Low	-1.95	-2.00

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.